Giant cell arteritis on 18F-FDG PET/CT

Thomas F. Heston, Zsolt Szabo

Research output: Contribution to journalArticle

Abstract

Purpose: We present a case of incidentally noted giant cell arteritis in a patient undergoing 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT imaging. The patient was originally referred to PET/ CT for staging of his renal transitional cell carcinoma. Methods: The patient was injected intravenously with 370 MBq of 18F-FDG. After a 60 min uptake period, PET/CT imaging was performed from the skull base to the mid thighs. Results: A small para-aortic node in the region of the surgical bed showed increased tracer uptake of concern for malignancy. In addition, there were several non-calcified pulmonary nodules present, also concerning for malignancy. Incidentally noted was diffusely increased tracer uptake throughout the aorta and a thickened aortic wall on CT images. Diffuse tracer uptake was also present in the proximal branches of the aorta, including the carotid, iliac, femoral, and subclavian arteries. The patient had biopsy proven giant cell arteritis. Conclusion: Increased 18F-FDG uptake by the aorta on PET/CT imaging is an abnormal finding that prompts a more thorough assessment for malignancy, and also can indentify important co-morbidities in cancer patients. Evaluation of aortic uptake should be a routine practice in the interpretation of 18F-FDG PET/CT scans.

Original languageEnglish (US)
Pages (from-to)382-384
Number of pages3
JournalClinical Physiology and Functional Imaging
Volume29
Issue number5
DOIs
StatePublished - 2009

Fingerprint

Giant Cell Arteritis
Fluorodeoxyglucose F18
Positron-Emission Tomography
Aorta
Neoplasms
Subclavian Artery
Transitional Cell Carcinoma
Iliac Artery
Skull Base
Femoral Artery
Thigh
Carotid Arteries
Renal Cell Carcinoma
Morbidity
Biopsy
Lung

Keywords

  • Fluorodeoxyglucose
  • Giant cell arteritis
  • Positron emission tomography/CT
  • Renal transitional cell carcinoma
  • Vasculitis

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Giant cell arteritis on 18F-FDG PET/CT. / Heston, Thomas F.; Szabo, Zsolt.

In: Clinical Physiology and Functional Imaging, Vol. 29, No. 5, 2009, p. 382-384.

Research output: Contribution to journalArticle

Heston, Thomas F. ; Szabo, Zsolt. / Giant cell arteritis on 18F-FDG PET/CT. In: Clinical Physiology and Functional Imaging. 2009 ; Vol. 29, No. 5. pp. 382-384.
@article{597ca6b4bd3d4aaf8f4bcd9e5a97b26b,
title = "Giant cell arteritis on 18F-FDG PET/CT",
abstract = "Purpose: We present a case of incidentally noted giant cell arteritis in a patient undergoing 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT imaging. The patient was originally referred to PET/ CT for staging of his renal transitional cell carcinoma. Methods: The patient was injected intravenously with 370 MBq of 18F-FDG. After a 60 min uptake period, PET/CT imaging was performed from the skull base to the mid thighs. Results: A small para-aortic node in the region of the surgical bed showed increased tracer uptake of concern for malignancy. In addition, there were several non-calcified pulmonary nodules present, also concerning for malignancy. Incidentally noted was diffusely increased tracer uptake throughout the aorta and a thickened aortic wall on CT images. Diffuse tracer uptake was also present in the proximal branches of the aorta, including the carotid, iliac, femoral, and subclavian arteries. The patient had biopsy proven giant cell arteritis. Conclusion: Increased 18F-FDG uptake by the aorta on PET/CT imaging is an abnormal finding that prompts a more thorough assessment for malignancy, and also can indentify important co-morbidities in cancer patients. Evaluation of aortic uptake should be a routine practice in the interpretation of 18F-FDG PET/CT scans.",
keywords = "Fluorodeoxyglucose, Giant cell arteritis, Positron emission tomography/CT, Renal transitional cell carcinoma, Vasculitis",
author = "Heston, {Thomas F.} and Zsolt Szabo",
year = "2009",
doi = "10.1111/j.1475-097X.2009.00881.x",
language = "English (US)",
volume = "29",
pages = "382--384",
journal = "Clinical Physiology and Functional Imaging",
issn = "1475-0961",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Giant cell arteritis on 18F-FDG PET/CT

AU - Heston, Thomas F.

AU - Szabo, Zsolt

PY - 2009

Y1 - 2009

N2 - Purpose: We present a case of incidentally noted giant cell arteritis in a patient undergoing 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT imaging. The patient was originally referred to PET/ CT for staging of his renal transitional cell carcinoma. Methods: The patient was injected intravenously with 370 MBq of 18F-FDG. After a 60 min uptake period, PET/CT imaging was performed from the skull base to the mid thighs. Results: A small para-aortic node in the region of the surgical bed showed increased tracer uptake of concern for malignancy. In addition, there were several non-calcified pulmonary nodules present, also concerning for malignancy. Incidentally noted was diffusely increased tracer uptake throughout the aorta and a thickened aortic wall on CT images. Diffuse tracer uptake was also present in the proximal branches of the aorta, including the carotid, iliac, femoral, and subclavian arteries. The patient had biopsy proven giant cell arteritis. Conclusion: Increased 18F-FDG uptake by the aorta on PET/CT imaging is an abnormal finding that prompts a more thorough assessment for malignancy, and also can indentify important co-morbidities in cancer patients. Evaluation of aortic uptake should be a routine practice in the interpretation of 18F-FDG PET/CT scans.

AB - Purpose: We present a case of incidentally noted giant cell arteritis in a patient undergoing 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT imaging. The patient was originally referred to PET/ CT for staging of his renal transitional cell carcinoma. Methods: The patient was injected intravenously with 370 MBq of 18F-FDG. After a 60 min uptake period, PET/CT imaging was performed from the skull base to the mid thighs. Results: A small para-aortic node in the region of the surgical bed showed increased tracer uptake of concern for malignancy. In addition, there were several non-calcified pulmonary nodules present, also concerning for malignancy. Incidentally noted was diffusely increased tracer uptake throughout the aorta and a thickened aortic wall on CT images. Diffuse tracer uptake was also present in the proximal branches of the aorta, including the carotid, iliac, femoral, and subclavian arteries. The patient had biopsy proven giant cell arteritis. Conclusion: Increased 18F-FDG uptake by the aorta on PET/CT imaging is an abnormal finding that prompts a more thorough assessment for malignancy, and also can indentify important co-morbidities in cancer patients. Evaluation of aortic uptake should be a routine practice in the interpretation of 18F-FDG PET/CT scans.

KW - Fluorodeoxyglucose

KW - Giant cell arteritis

KW - Positron emission tomography/CT

KW - Renal transitional cell carcinoma

KW - Vasculitis

UR - http://www.scopus.com/inward/record.url?scp=69149095805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69149095805&partnerID=8YFLogxK

U2 - 10.1111/j.1475-097X.2009.00881.x

DO - 10.1111/j.1475-097X.2009.00881.x

M3 - Article

C2 - 19522856

AN - SCOPUS:69149095805

VL - 29

SP - 382

EP - 384

JO - Clinical Physiology and Functional Imaging

JF - Clinical Physiology and Functional Imaging

SN - 1475-0961

IS - 5

ER -